Trial · NCT01080391
Adverse events904
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 904
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Lenalidomide and Dexamethasone (Rd) | 154 | 389 | |
| other | Anaemia | Blood and lymphatic system disorders | Carfilzomib, Lenalidomide, and Dexamethasone (CRd) | 166 | 392 | |
| other | Leukopenia | Blood and lymphatic system disorders | Lenalidomide and Dexamethasone (Rd) | 22 | 389 | |
| other | Leukopenia | Blood and lymphatic system disorders | Carfilzomib, Lenalidomide, and Dexamethasone (CRd) | 33 | 392 | |
| other | Neutropenia | Blood and lymphatic system disorders | Lenalidomide and Dexamethasone (Rd) | 133 | 389 | |
| other | Neutropenia | Blood and lymphatic system disorders | Carfilzomib, Lenalidomide, and Dexamethasone (CRd) | 157 | 392 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Lenalidomide and Dexamethasone (Rd) | 94 | 389 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Carfilzomib, Lenalidomide, and Dexamethasone (CRd) | 115 | 392 | |
| other | Cataract | Eye disorders | Lenalidomide and Dexamethasone (Rd) | 36 | 389 | |
| other | Cataract | Eye disorders | Carfilzomib, Lenalidomide, and Dexamethasone (CRd) | 39 | 392 | |
| other | Vision blurred | Eye disorders | Lenalidomide and Dexamethasone (Rd) | 15 | 389 | |
| other | Vision blurred | Eye disorders | Carfilzomib, Lenalidomide, and Dexamethasone (CRd) | 24 | 392 | |
| other | Abdominal pain | Gastrointestinal disorders | Lenalidomide and Dexamethasone (Rd) | 27 | 389 | |
| other | Abdominal pain | Gastrointestinal disorders | Carfilzomib, Lenalidomide, and Dexamethasone (CRd) | 32 | 392 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Lenalidomide and Dexamethasone (Rd) | 12 | 389 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Carfilzomib, Lenalidomide, and Dexamethasone (CRd) | 28 | 392 | |
| other | Constipation | Gastrointestinal disorders | Lenalidomide and Dexamethasone (Rd) | 69 | 389 | |
| other | Constipation | Gastrointestinal disorders | Carfilzomib, Lenalidomide, and Dexamethasone (CRd) | 81 | 392 | |
| other | Diarrhoea | Gastrointestinal disorders | Lenalidomide and Dexamethasone (Rd) | 143 | 389 | |
| other | Diarrhoea | Gastrointestinal disorders | Carfilzomib, Lenalidomide, and Dexamethasone (CRd) | 170 | 392 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01080391/events